Search Market Research Report
AI Radiation Dosing Market Size, Share Global Analysis Report, 2022 – 2028
AI Radiation Dosing Market Size, Share, Growth Analysis Report By Type of Modalities (MRI, Ultrasound, Mammography, Computed Tomography (CT) Scan, X-ray and Others), By End User (Hospitals, Medical Institutions, Diagnostic Center and Other Medical Groups), and By Region- Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028
Industry Insights
[210+ Pages Report] According to Facts and Factors, the Global AI Radiation Dosing market size was worth USD 236.40 million in 2021 and is estimated to grow to USD 1084.34 million by 2028, with a compound annual growth rate (CAGR) of approximately 28.90% over the forecast period. The report analyzes the AI Radiation Dosing market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the AI Radiation Dosing market.
Market Overview
Artificial intelligence and radiation dosage management are combined in AI radiation dosing. The number of radiations that a patient receiving medical treatment's body absorbs is known as the radiation dosage. The monitoring and gauging of these radiations are required to reduce the adverse impacts that these radiations have on the body parts, and it is anticipated that this will aid in the globalization of the AI radiation dosing market. Five general areas of molecular imaging and radiation therapy, including image denoising (low-dose imaging), radiation dosimetry, computer-aided diagnostics, and PET image reconstruction quantification and segmentation, have all seen the application of artificial intelligence. In addition, the high prevalence of chronic diseases, growing elderly population, patients' growing safety concerns, and the requirement to raise the level of patient care in developing countries in the Asia Pacific, the Middle East & Africa, and Latin America will all contribute to the growth of the market for AI radiation dosing.
Along with this, the need to lower high radiation doses and a rise in government investment in building sturdy healthcare infrastructure facilities will support the market's future expansion. The AI, radiation dosing market is anticipated to grow over the forecast period as a result of increased R&D activities and expanding healthcare infrastructure. The application of AI innovation in disease care is anticipated to increase analysis' accuracy and speed, support clinical dynamics, and produce better outcomes. For instance, the US-based radiation oncology medical equipment maker Varian Medical Systems recently unveiled the Ethos artificial intelligence radiotherapy device. The latest AI developments assist in accelerating this process, which traditionally takes days to create an improved radiation therapy conveyance plan.
COVID-19 Impact:
Every part of the medical device business, including radiation devices, has been impacted by the COVID-19 epidemic. The COVID-19 epidemic has resulted in significant regional variance in managing radiation procedures. COVID-19 is predicted to result in a 20% increase in cancer burden worldwide. As governments and authorities work to guarantee that resources are available for COVID-19 patients, this can be attributed to the temporary postponement of a number of elective procedures.
In order to lessen the burden on the healthcare system, reduce disease transmission, and preserve personal protective equipment, several governments have set recommendations for elective procedures (PPE). Reduced enrollment in clinical trials and shuttered manufacturing facilities as a result of lockdowns have further hampered the expansion of the market for AI radiation dosing as a whole.
Key Insights
- AI Radiation Dosing market share value at a CAGR of 28.90% over the forecast period.
- The ophthalmic, urological, neuromuscular, gastrointestinal, and cardiovascular applications in medical applications are among the sectors driving the worldwide AI Radiation Dosing market.
- By type of modalities, the Computed Tomography (CT) Scan segment will dominate the market in 2021.
- By end users, the hospital's segment will dominate the market in 2021.
- North America will dominate the Global AI Radiation Dosing market in 2021.
Growth Drivers
- AI technology facilitates low-dose CT scanning likely to pave the way for global market growth
Radiation exposure has recently become a top worry for patients getting CT scans and being exposed to X-ray radiation from the scans. Low radiation dosage CT scans have been made possible by applying artificial intelligence radiation dosing, which has greatly reduced patient anxiety. The market for AI radiation doses is anticipated to increase as a result of all the aforementioned causes in the coming years. Lowering the radiation may result in a decrease in image quality. Therefore, engineers worldwide have been concentrating and prioritizing the development of efficient iterative reconstruction techniques to eliminate the intrusions from the CT scan pictures.
Restraints
- The lack of appropriate healthcare infrastructure may hamper the global market growth
The greater size of radiotherapy equipment necessitates a huge installation area. As a result, one of the main barriers to implementing AI Radiation Dosing in emerging and developing economies is the lack of an appropriate healthcare infrastructure caused by low healthcare spending. In addition, only a small percentage of healthcare facilities in emerging and impoverished nations now have access to advanced radiation technologies for cancer treatment. As a result, fewer radiation procedures are being performed despite their great demand.
Opportunities
- Technological advancements bring up several growth opportunities
Over the past ten years, significant technological improvements have occurred in the AI radiation dosing sector. These developments have contributed to the creation of more efficient, affordable, and simple-to-use radiotherapy systems that deliver radiation doses more precisely and effectively, making it easier to target malignancies. In addition, the transition from 2D to 3D conformal radiotherapy with real-time imaging has made it possible to increase the dose with better tumour control while maintaining high radiation conformance to the target (with little exposure to normal tissue). These technological developments concentrate on enhancing the efficiency of radiation delivery systems and broadening the scope of their applications. One of the key factors fueling the expansion of the AI radiation dosing market is the increasing acceptance of these systems across various settings and applications.
Segmentation Analysis
The global AI Radiation Dosing market is segregated on the basis of type of modalities, end user, and region.
By type of modalities, the market is divided into MRI, Ultrasound, Mammography, Computed Tomography (CT) Scan, X-ray and Others. Among these, the Computed Tomography (CT) Scan segment will dominate the market in 2021. Since CT scans can provide tailored scan images of specific body parts of patients, the segment's rise can be attributable to the industry's extensive use in healthcare. The usage of CT scans in orthopedic, neurologic, and cancer conditions will enhance the segment's rise. The ultrasound modality segment is expected to expand during the forecast period.
The end user divides the market into Hospitals, Medical Institutions, Diagnostic centers and Other Medical Groups. In 2021, the Hospitals segment is expected to develop at the fastest rate due to the large patient population base and the ease with which finances may be raised for the implementation of new services. In addition, widespread patient knowledge of the benefits of early disease identification and the harmful effects of radiation exposure will increase the need for AI radiation dosing in hospitals. The considerable growth of the hospital segment is expected to be further aided by technical advancements in imaging modalities throughout the forecast period. During the assessment period, the diagnostic center segment is expected to expand significantly.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 236.40 Million |
Projected Market Size in 2028 |
USD 1084.34 Million |
CAGR Growth Rate |
28.90% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Bayer HealthCare LLC., Imalogix, Siemens Healthcare Private Limited, and Others |
Key Segment |
By Type of Modalities, End User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Recent Developments
- In June 2021 - Avicenna. AI reported that the FDA had approved its CINA-LVO, CINA-ICH, and neurovascular emergency applications, all of which are available on the Nuance AI marketplace. With a single point of access to a wide range of AI diagnostic models within the radiology reporting platform, this is the biggest and first gateway of its kind in the United States.
- In June 2021 - the manufacturing process technology transfer between Perimeter Medical Imaging AI and Minnetronix Medical was completed successfully. It will be used to create optical coherence tomography (OCT) imaging equipment.
Regional Landscape
- Strong acceptance of HCIT procedures is likely to help North America dominate the global market
North America is expected to dominate the AI Radiation Dosing Market in 2021. The North American market is anticipated to experience the largest regional revenue growth over the course of the forecast period due to stringent regulations and certification requirements for reporting and radiation dose optimization. Along with this, the region's growth will also be fueled by the strong acceptance of HCIT procedures and the stringent use of dose protocols to improve patient safety during CT scans in nations like the U.S.
Over the forecast period, Asia Pacific regional market is expected to grow significantly in AI Radiation Dosingmarket in 2021. The presence of growing important market players, growing healthcare infrastructure, large patient populations for target diseases, and growing patient populations for target diseases are the main factors driving market expansion in this region.
Competitive Landscape
Key players within the global AI radiation dosing market include
- Bayer HealthCare LLC.
- Imalogix
- Siemens Healthcare Private Limited
The global AI Radiation Dosing market is segmented as follows:
By Type of Modalities
- MRI
- Ultrasound
- Mammography
- Computed Tomography (CT) Scan
- X-ray
- Others
By End User
- Hospitals
- Medical Institutions
- Diagnostic Center
- Other Medical Groups
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Content
Industry Major Market Players
- Bayer HealthCare LLC.
- Imalogix
- Siemens Healthcare Private Limited
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors